Get the Stockscreener App
12.96
1.89%
0.24
Gh Research Plc stock is traded at $12.96, with a volume of 760.46K.
It is up +1.89% in the last 24 hours and down -9.87% over the past month.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
See More
Previous Close:
$12.72
Open:
$12.84
24h Volume:
760.46K
Relative Volume:
2.30
Market Cap:
$803.90M
Revenue:
-
Net Income/Loss:
$-41.43M
P/E Ratio:
-16.41
EPS:
-0.79
Net Cash Flow:
$-39.97M
1W Performance:
-0.58%
1M Performance:
-9.87%
6M Performance:
+9.46%
1Y Performance:
+75.37%
1-Day Range:
$12.63
$13.33
1-Week Range:
$12.04
$13.37
52-Week Range:
$6.72
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
12.96 | 789.01M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.20 | 113.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
767.96 | 78.69B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.23 | 52.32B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.99 | 52.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.84 | 35.52B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Jun-04-25 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-13-25 | Initiated | Guggenheim | Buy |
| Mar-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Feb-13-25 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-16-22 | Initiated | H.C. Wainwright | Buy |
| Jun-16-22 | Initiated | ROTH Capital | Buy |
View All
Gh Research Plc Stock (GHRS) Latest News
Pattern Scan Adds Hindustan Media Ventures Limited to WatchlistWeekly Trade Summary & Free Community Supported Trade Ideas - Bollywood Helpline
Is GH Research PLC (1KA) stock a defensive play amid uncertaintyWeekly Profit Summary & Fast Moving Stock Trade Plans - Bölüm Sonu Canavarı
Will GH Research PLC stock outperform growth indexesWeekly Profit Report & Fast Momentum Stock Entry Tips - Улправда
Will GH Research PLC (1KA) stock gain from green policies2025 Trading Recap & Reliable Price Breakout Signals - Улправда
Can Cyngn Inc. stock reach $100 price targetJuly 2025 Institutional & Fast Moving Stock Trade Plans - Улправда
Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - MSN
GH Research to Present Promising Results on GH001 at ACNP 2026 - MSN
We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth - Sahm
Technical Analysis: Jindal Poly Films Limited (500227) - earlytimes.in
Stempoint Capital LP Acquires New Stake in GH Research PLC $GHRS - MarketBeat
Understanding Momentum Shifts in (GHRS) - news.stocktradersdaily.com
GH Research PLC (NASDAQ:GHRS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
GH Research PLC (NASDAQ:GHRS) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Hsbc Holdings PLC Grows Position in Guardant Health, Inc. $GH - MarketBeat
Is GH Research PLC (1KA) stock worth holding before Fed meetingJuly 2025 Final Week & High Yield Stock Recommendations - Newser
Will GH Research PLC stock see PE expansionJuly 2025 Decliners & Daily Entry Point Alerts - Newser
How GH Research PLC (1KA) stock correlates with oil marketsTrade Volume Summary & Risk Controlled Stock Pick Alerts - Newser
GH Research (GHRS) Stock Analysis Report | Financials & Insights - Benzinga
Can GH Research PLC (1KA) stock deliver consistent EPS growthJuly 2025 Sentiment & Verified Momentum Watchlists - Newser
Why retail investors pile into GH Research PLC stockJobs Report & Growth Focused Investment Plans - Newser
Avoiding Lag: Real-Time Signals in (GHRS) Movement - news.stocktradersdaily.com
Taking on analysts’ expectations and winning: GH Research PLC (GHRS) - Setenews
GH Research PLC accepted for Promising Targets oral session at ACNP - Stock Titan
What drives GH Research PLC (1KA) stock priceVolume Spike Alerts & Start Learning With Our Courses - earlytimes.in
GH Research PLC Reports Q3 2025 Financial Results - MSN
Will GH Research PLC stock gain from strong economyQuarterly Profit Review & Community Driven Trade Alerts - newser.com
Will GH Research PLC (1KA) stock benefit from sector leadership2025 Top Decliners & Smart Swing Trading Techniques - newser.com
Is GH Research PLC (1KA) stock attractive post correctionWeekly Stock Analysis & AI Based Buy/Sell Signal Reports - newser.com
Live market analysis of GH Research PLCJuly 2025 Big Picture & Risk Controlled Daily Plans - newser.com
Will GH Research PLC (1KA) stock rise with strong economy2025 Price Momentum & Fast Exit Strategy with Risk Control - newser.com
Is GH Research PLC stock dividend yield sustainableStop Loss & Accurate Trade Setup Notifications - newser.com
Understanding GH Research PLC’s price movementDip Buying & Long-Term Growth Stock Strategies - newser.com
Why GH Research PLC stock is favored by pension fundsTrade Analysis Summary & Verified Stock Trade Ideas - newser.com
Is GH Research PLC stock oversold or undervaluedPortfolio Update Summary & AI Forecasted Stock Moves - newser.com
GH Research PLC stock chart pattern explainedJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Historical volatility pattern of GH Research PLC visualized2025 Market Outlook & AI Forecasted Entry/Exit Points - newser.com
Gh Research Plc Stock (GHRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):